SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced the launch of the V.A.C.RX4™ Therapy System in the United States. The V.A.C.RX4™ System was initially developed at the request of the U.S. Air Force and U.S. Department of Defense to help military personnel treat multiple battlefield wounds with a single negative pressure wound therapy (NPWT) device and was designed to meet safe-to-fly requirements. The device is now available to civilian healthcare professionals, allowing more clinicians to effectively manage multiple wounds on trauma patients.
“In trauma centers and burn units, physicians encounter patients who are suffering from multiple wounds that could benefit from negative pressure wound therapy without an effective, convenient way to do so,” said R. Andrew Eckert, President and CEO of KCI, an Acelity Company. “As an organization, we are committed to expanding the boundaries of what’s possible in wound healing so that we may develop innovative new solutions for our customers, while also increasing ease of use and maintaining the highest standards of care. The V.A.C.RX4™ System is yet another example of our ability to deliver upon that commitment.”
Prior to the introduction of the V.A.C.RX4™ System, hospitals and clinicians did not have the ability to independently treat more than one wound per patient. Now with the V.A.C.RX4™ System, its innovative multichannel design utilizing proprietary SENSAT.R.A.C.™ Technology enables constant pressure to be delivered to multiple wounds at the same time, delivering efficiency and simplicity in the healthcare system for trauma and burn patients.
“At University Clinical Health we have been utilizing negative pressure wound therapy on our patients for quite some time with good results,” said Dr. William Hickerson, MD, FACS, University Clinical Health. “Having the ability to confidently treat patients with multiple wounds through one easy-to-use, multichannel NPWT device with the V.A.C.RX4™ System allows us to enhance outcomes in the patients who need it most.”
About V.A.C.® Therapy System
V.A.C.® Therapy changed the practice of medicine with its introduction in 1995. With more published clinical evidence than any other form of negative pressure wound therapy, it has been selected as the treatment of choice for more than 10 million wounds worldwide.1 With the use of patented SENSAT.R.A.C.™ Technology, V.A.C.® Therapy Systems are designed to accurately deliver the selected negative pressure at the wound site for optimal healing.
About KCI, an Acelity Company
KCI, an Acelity Company, is a well trusted brand in advanced wound care. We have built upon our pioneering market leadership in negative pressure wound therapy and revolutionized advanced wound care, providing solutions for both wound healing and surgical management. Our unsurpassed product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing, KCI sets the standard for leading advanced wound therapy innovation.
1 KCI. Number of Wounds Treated by NPWT. July 2018
